{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-012575","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.142461+00:00","generated_at":"2026-05-17T00:39:21.281552+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Zomedica Q3 2025 revenue $8.1M (+16% YoY); net loss narrows to $6.1M","bullets":["Revenue $8.1M, up 16% YoY; gross margin 67%; Diagnostics segment grew 51%.","Net loss $6.1M (down 9% YoY); adjusted EBITDA loss $3.9M.","Cash and securities $54.4M; operating expenses reduced $0.5M in Q3.","New Development Services segment generated $0.7M revenue in first quarter.","Record revenue for 19th straight quarter; new distribution agreements in UK, Netherlands, Canada."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-012575","json":"https://secwatch.observer/filing/0001654954-25-012575.json","markdown":"https://secwatch.observer/filing/0001654954-25-012575.md","text":"https://secwatch.observer/filing/0001654954-25-012575.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495425012575/0001654954-25-012575-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495425012575/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:39:21.281552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}